Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.

Author: BaladiMichelle, BronMorgan, RosenbergRussell

Paper Details 
Original Abstract of the Article :
STUDY OBJECTIVES: To evaluate the clinical relevance of solriamfetol in treating excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea (OSA). METHODS: This posthoc analysis includes data from two 12-week, randomized phase 3 studies in participants with narcolepsy o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020685/

データ提供:米国国立医学図書館(NLM)

Solriamfetol: A Potential Oasis in the Desert of Excessive Sleepiness

Excessive daytime sleepiness can significantly impact daily life, leaving individuals feeling drained and exhausted like a weary traveler traversing a vast desert. This research evaluates the effectiveness of solriamfetol, a novel medication, in treating excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea. The study analyzes data from two randomized controlled trials, investigating the impact of solriamfetol on sleepiness levels and overall well-being. The research offers a beacon of hope for individuals struggling with excessive daytime sleepiness, potentially leading to a more refreshed and energized life.

Solriamfetol: A Promising Solution for Excessive Sleepiness

The study reveals that solriamfetol demonstrates significant efficacy in reducing excessive daytime sleepiness in individuals with narcolepsy and obstructive sleep apnea. A substantial percentage of participants treated with solriamfetol experienced a clinically meaningful improvement in their sleepiness levels, as measured by the Epworth Sleepiness Scale. These findings suggest that solriamfetol could offer a valuable treatment option for individuals struggling with excessive daytime sleepiness, potentially transforming their lives.

A Brighter Future for Those with Sleep Disorders: A Journey Towards Better Sleep

This research provides a glimmer of hope for individuals battling excessive daytime sleepiness, demonstrating the potential of solriamfetol as an effective treatment option. The findings suggest that solriamfetol could help individuals reclaim their energy levels and improve their overall quality of life. This research paves the way for a more promising future for individuals struggling with sleep disorders, offering the potential for a better night's rest and a more fulfilling day.

Dr. Camel's Conclusion

This research explores the potential of solriamfetol as a treatment option for excessive daytime sleepiness, demonstrating its effectiveness in reducing sleepiness levels and improving overall well-being in individuals with narcolepsy and obstructive sleep apnea. This study offers a promising avenue for alleviating the debilitating effects of excessive daytime sleepiness and improving the quality of life for individuals struggling with these conditions.

Date :
  1. Date Completed 2021-06-29
  2. Date Revised 2022-05-31
Further Info :

Pubmed ID

33226332

DOI: Digital Object Identifier

PMC8020685

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.